CD274 and plasma cell myeloma: Similar to our findings, previous studies [11-12] showed that the serum soluble PD-L1 level in multiple myeloma patients was a negative prognostic factor. This finding also suggested that the activation of the PD-L1 pathway correlates with disease relapse.